Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines
Immuno-Oncology Insights 2024; 5(1), 65–74
DOI: 10.18609/ioi.2024.010
Published: 20 March
Interview
Roy de Souza, David Hawke
Lauren Coyle, Commissioning Editor,Immuno-Oncology Insights, speaks with Roy de Souza and David Hawke, co-founders of BreakBio, about innovative strategies for personalized cancer vaccines and the transformative potential of early intervention in cancer.